T Masaoka - Concepedia

Author

T Masaoka

Osaka International Cancer Institute

Also Known As

M Hattori, Masaoka, Tohru, R Ohno, T Masaoka, T. Masaoka, TOHRU MASAOKA, Tohru MASAOKA, Tohru Masaoka

224

Publications

4.2K

Citations

H-Index

Concepts

All Affiliations

Osaka International Cancer Institute The University of Osaka Kindai University Medical College of Wisconsin Nagoya University

About

T Masaoka is an author at Osaka International Cancer Institute specializing in medicine, immunology, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	31	1.3K
2	Health Sciences	9	9	244
3	Cell Biology	6	6	118
4	Blood Transplantation	3	3	109
5	Engineering	1	1	43

T Masaoka

Publications

3.9K

Citations

H-Index

Page 1

	Year	Citations
WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia Kazushi Inoue, Haruo Sugiyama, Hiroyasu Ogawa, Blood	1994	575
Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. Richard Szydlo, John M. Goldman, John P. Klein, Journal of Clinical Oncology	1997	474
Effect of Granulocyte Colony-Stimulating Factor after Intensive Induction Therapy in Relapsed or Refractory Acute Leukemia Ryuzo Ohno, Masao Tomonaga, Tohru Kobayashi, New England Journal of Medicine	1990	396
An early phase II study of CPT-11: a new derivative of camptothecin, for the treatment of leukemia and lymphoma. R Ohno, Kosuke Okada, T Masaoka, Journal of Clinical Oncology Hematological MalignancyTumor BiologyLymphoid NeoplasiaOncologyRefractory Cases	1990	229
Bone marrow transplantation from related donors other than HLA-identical siblings: effect of T cell depletion. Robert C. Ash, Mary M. Horowitz, Robert Peter Gale, PubMed	1991	198
Methotrexate, cyclosporine, or both to prevent graft-versus-host disease after HLA-identical sibling bone marrow transplants for early leukemia? Olle Ringdén, MM Horowitz, Paul M. Sondel, Blood	1993	168
Phase III study comparing tacrolimus (FK506) with cyclosporine for graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation A Hiraoka, Yasuo Ohashi, Shinichiro Okamoto, Bone Marrow Transplantation TransplantationImmunosuppressive TherapyGraft-versus-host Disease ProphylaxisImmunologyAutoimmunity	2001	155
Evidence‐Based Recommendations for Antimicrobial Use in Febrile Neutropenia in Japan: Executive Summary T Masaoka Clinical Infectious Diseases Antimicrobial SusceptibilityAntibioticsAntimicrobial StewardshipEvidence‐based RecommendationsHealthcare-associated Infection	2004	120
Randomized study of individualized induction therapy with or without vincristine, and of maintenance—intensification therapy between 4 or 12 courses in adult acute myeloid leukemia. AML-87 study of the Japan adult leukemia study group Ryuzo Ohno, Tohru Kobayashi, Mitsune Tanimoto, Cancer	1993	101
Vidarabine therapy for virus-associated cystitis after allogeneic bone marrow transplantation M Kawakami, Seiji Ueda, Tomoya Maeda, Bone Marrow Transplantation TransplantationImmunosuppressive TherapyImmunologyHematologyAntiviral Therapy	1997	79

Page 1